Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation
Victoria Higgins, Anselmo Fabros, Vathany Kulasingam
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 4
Open Access | Times Cited: 128

Showing 26-50 of 128 citing articles:

Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1750-1756
Open Access | Times Cited: 29
Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
Yoonjoo Kim, Ji Hyun Lee, Geon Young Ko, et al.
Diagnostics (2021) Vol. 11, Iss. 8, pp. 1496-1496
Open Access | Times Cited: 38
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer
Thomas Mueller
Clinica Chimica Acta (2021) Vol. 518, pp. 9-16
Open Access | Times Cited: 36
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents
Ignacio Torres, Eliseo Albert, Estela Giménez, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1672-1677
Open Access | Times Cited: 34
Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy
Lior Kashani Ligumsky, Miriam Lopian, Ronnie Cohen, et al.
Journal of Perinatology (2021) Vol. 41, Iss. 11, pp. 2621-2624
Open Access | Times Cited: 32
Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
Sarah Frey, Teresa Po‐Yu Chiang, Caoilfhionn M Connolly, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 4, pp. e241-e243
Open Access | Times Cited: 24
Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients
Pierluigi Toniutto, Annarosa Cussigh, Sara Cmet, et al.
Liver International (2022) Vol. 43, Iss. 2, pp. 452-461
Open Access | Times Cited: 23
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
Mahak Chauhan, Ihechiluru Nzeako, Feng Li, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 4, pp. 100702-100702
Open Access | Times Cited: 22
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis
Mobin Azami, Yousef Moradi, Asra Moradkhani, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
Felix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 2, pp. 292-300
Open Access | Times Cited: 22
Clinical Significance of Neutralizing Antibodies in COVID-19: Implications for Disease Prognosis
Sudem Mahmutoğlu Çolak, Tuba İlgar, İlkay Bahçeci, et al.
Life (2025) Vol. 15, Iss. 3, pp. 429-429
Open Access
Fluorescence polarization assays: Another mainstream in detection of biohazards
Chang Yeol Lee, Juyeon Jung
Microchemical Journal (2025), pp. 113523-113523
Closed Access
Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
Mayan Teles, Caoilfhionn M Connolly, Sarah Frey, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 5, pp. 738-740
Open Access | Times Cited: 21
The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study
Thomas Perkmann, Patrick Mucher, Nicole Perkmann‐Nagele, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
Peter Bergman, David Wullimann, Yu Gao, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 4, pp. 716-727
Open Access | Times Cited: 19
Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination
Nayara Panizo, Eliseo Albert, Elena Giménez-Civera, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 8, pp. 1562-1573
Open Access | Times Cited: 19
Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers
Seri Jeong, Nuri Lee, Su Kyung Lee, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 9
Open Access | Times Cited: 25
Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay
Davor Brinc, Mia J. Biondi, Daniel Li, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 962-962
Open Access | Times Cited: 24
Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers
Miku Nakai, Daisuke Yokoyama, Tomoaki Sato, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16547-e16547
Open Access | Times Cited: 10
The Levels of Anti-SARS-CoV-2 Spike Protein IgG Antibodies Before and After the Third Dose of Vaccination Against COVID-19
Małgorzata Łysek-Gładysińska, Magdalena Starz, Agnieszka Borowiec-Sęk, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 145-160
Open Access | Times Cited: 9
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents
Eliseo Albert, Javier S. Burgos, Salvador Peiró, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 279-284
Open Access | Times Cited: 21
Facile and rapid detection of SARS-CoV-2 antibody based on a noncompetitive fluorescence polarization immunoassay in human serum samples
Keine Nishiyama, Kazuki Takahashi, Mao Fukuyama, et al.
Biosensors and Bioelectronics (2021) Vol. 190, pp. 113414-113414
Open Access | Times Cited: 20
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis
Elisabeth Simader, Selma Tobudic, Péter Mandl, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 416-421
Closed Access | Times Cited: 20
Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age
Richard Tanner, Neasa Starr, Grace Chan, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 41, Iss. 4, pp. 492-500
Open Access | Times Cited: 15
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8485-8485
Open Access | Times Cited: 15

Scroll to top